vimarsana.com
Home
Live Updates
FDA approval of new gene therapy to treat Duchenne muscular
FDA approval of new gene therapy to treat Duchenne muscular
FDA approval of new gene therapy to treat Duchenne muscular dystrophy grants hope to 4-year-old SoCal boy
A first-of-its-kind gene therapy was approved to treat Duchenne muscular dystrophy, a devastating condition affecting 1 out of 3,500 to 5,000 boys.
Related Keywords
Los Angeles ,
California ,
United States ,
Sacramento ,
Thomas Kargar ,
Leigh Maria Ramos Platt ,
Zac Kargar ,
Nicole Orellana ,
Children Hospital Los Angeles Neuromuscular Program ,
,
Duchenne Muscular Dystrophy ,
Elevidys ,
Gene Therapy ,
Fda ,
Condition ,
Boys ,
Health ,
Revolutionary ,
Medical ,
Medical Treatment ,
Hild Patient ,